111 related articles for article (PubMed ID: 3203007)
21. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Azab MB; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset JM; Caillou B; Droz JP
Cancer; 1989 Sep; 64(6):1208-17. PubMed ID: 2670184
[TBL] [Abstract][Full Text] [Related]
22. [Value of the Kiel morphological classification in the clinical aspects of non-Hodgkin's lymphoma].
Glińska H; Papla B; Siuda M; Zulichowska J
Przegl Lek; 1989; 46(11):757-61. PubMed ID: 2623182
[TBL] [Abstract][Full Text] [Related]
23. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
24. [Analysis for clinicopathological features, therapy and prognosis of 30 elderly patients with non-Hodgkin's lymphoma].
Wang HT; Yang B; Cai LL; Ran HH; Zhang WY; Zhu HL; Yang Y; Li SX; Fan H; Chi XH; Yu RL; Zhang F; Li BL; Lin J; Zhai B; Yao SQ; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1464-70. PubMed ID: 24370030
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.
Armitage JO; Vose JM; Linder J; Weisenburger D; Harrington D; Casey J; Bierman P; Sorensen S; Hutchins M; Moravec DF
J Clin Oncol; 1989 Dec; 7(12):1783-90. PubMed ID: 2585020
[TBL] [Abstract][Full Text] [Related]
26. Primary peripheral nodal lymphoma in children.
Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
[TBL] [Abstract][Full Text] [Related]
27. Non-Hodgkin's lymphoma in Pakistan: a clinicopathological profile of 175 patients.
Aziz Z; Rehman A; Akram M; Saeed A
J Pak Med Assoc; 1999 Jan; 49(1):11-5. PubMed ID: 10463009
[TBL] [Abstract][Full Text] [Related]
28. [Experience with results of treatment of non-Hodgkin's lymphoma].
Gurzó M; Dobos K; Bérczi M; Varga G; Kelényi G
Orv Hetil; 1992 May; 133(18):1091-7. PubMed ID: 1579348
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
Coiffier B; Gisselbrecht C; Vose JM; Tilly H; Herbrecht R; Bosly A; Armitage JO
J Clin Oncol; 1991 Feb; 9(2):211-9. PubMed ID: 1703226
[TBL] [Abstract][Full Text] [Related]
31. Primary non-Hodgkin lymphoma of the stomach--role of surgery.
Steinau G; Riesener KP; Schleef J; Steinau B; Schumpelick V
Hepatogastroenterology; 1997; 44(17):1513-8. PubMed ID: 9356882
[TBL] [Abstract][Full Text] [Related]
32. A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.
Steward WP; Todd ID; Harris M; Jones JM; Blackledge G; Wagstaff J; Anderson H; Wilkinson PM; Crowther D
Eur J Cancer Clin Oncol; 1984 Jul; 20(7):881-9. PubMed ID: 6547675
[TBL] [Abstract][Full Text] [Related]
33. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors of extranodal non-Hodgkin's lymphoma--an analysis of 62 cases].
Fu HP
Zhonghua Zhong Liu Za Zhi; 1990 Jul; 12(4):310-3. PubMed ID: 2272271
[TBL] [Abstract][Full Text] [Related]
35. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
Ding SL; Ko WS; Hwang WS
J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
[TBL] [Abstract][Full Text] [Related]
36. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.
Li YX; Coucke PA; Li JY; Gu DZ; Liu XF; Zhou LQ; Mirimanoff RO; Yu ZH; Huang YR
Cancer; 1998 Aug; 83(3):449-56. PubMed ID: 9690537
[TBL] [Abstract][Full Text] [Related]
37. Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma.
Mok TS; Steinberg J; Chan AT; Yeo WM; Hui P; Leung TW; Johnson P
Cancer; 1998 Jun; 82(12):2439-48. PubMed ID: 9635538
[TBL] [Abstract][Full Text] [Related]
38. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
[TBL] [Abstract][Full Text] [Related]
39. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
40. Extranodal lymphomas of the head and neck. A 20-year experience.
Hanna E; Wanamaker J; Adelstein D; Tubbs R; Lavertu P
Arch Otolaryngol Head Neck Surg; 1997 Dec; 123(12):1318-23. PubMed ID: 9413361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
